Avita Medical | 1811094D - Ebitda



金融业
股票价格
AUD
资产
AUD 56.39M
现金及等价物
AUD 10.24M
销售成本
AUD 3.3M
流动资产
AUD 35.49M
流动负债
AUD 62.68M
债务
AUD 46.05M
EBIT
AUD -10.39M
EBITDA
AUD -9.69M
员工
AUD 87
EPS每股收益
AUD -0.38
股本和储备
AUD -16.65M
销售毛利
AUD 14.31M
债务利息支出
AUD 1.25M
贷款资金
AUD 42.25M
市值
AUD 151.43M
净收入
AUD -11.62M
营业费用
AUD 28.02M
营业利润
AUD -10.41M
税前利润
AUD -11.64M
销售收入
AUD 17.62M
销售和管理费用
AUD 19.03M
股票
AUD 6.93M
贸易债权人
AUD 8.96M
应收帐款人
AUD 9.11M


Ebitda 更改 日
Accuray USD -685K 900K 2024-09
Celltrion KRW 19.64B 1.85B 2026-03
Clinuvel Pharmaceuticals AUD 27.55M 12.65M 2025-06
Cochlear AUD 306.4M 13.5M 2025-12
CSL USD 3.13B 1.17B 2025-12
Cspc Pharmaceutical CNY 2.19B 21.88M 2024-12
Deva Holding AS TRY 882.9M 201.7M 2023-09
Dianthus Therapeutics USD -46.46M 6.27M 2026-03
Divis Laboratories Ltd INR 9.34B 440M 2026-03
Kangmei Pharma CNY -12.72M 30.02M 2026-03
Knight Therapeutics CAD 24.45M 3.46M 2025-12
Laboratorios Farma EUR 34.94M 102.95M 2025-06
Malin Corporation EUR -1.1M 200K 2024-12
Mayne Pharma AUD 20.9M 5.2M 2025-06
Medical Developments International AUD 1.78M 3.78M 2024-12
Nanosonics AUD 12.49M 1.13M 2025-12
Neuren Pharmaceuticals AUD 11.14M 165.56M 2025-12
Organigram Holdings CAD -4.76M 10.02M 2026-03
Pacific Edge NZD -13.97M 332K 2024-09
Paradigm Biopharmaceuticals AUD -5.86M 3.79M 2024-12
Pharma Mar EUR 2.71M 42.25M 2026-03
Polynovo AUD 3.89M 100K 2025-12
PYC Therapeutics AUD -22.79M 1.5M 2025-12
Qiagen NV USD 249.69M 56.53M 2025-12
Ramsay Health Care AUD 1.12B 10.6M 2025-12
ResMed USD 568.84M 21.36M 2026-03
Sartorius EUR 267.3M 10.1M 2026-03
Sino Biopharmaceutical CNY 2.59B 1.57B 2024-12
Telix Pharmaceuticals AUD 18.42M 14.82M 2025-12
Tilray USD 8.36M 1.82M 2025-09
Zealand Pharma A/S -727.47M 285.54M 2025-12
Zhangzhou Pientzehuang Pharmaceutical CNY 882.7M 351.1M 2026-03